The performance peptide market is growing fastest in the segment that big telehealth brands largely ignore: fitness-oriented adults who want to change their body composition, not just lose weight.
GLP-1 programs have captured the weight loss conversation. But there is a large, underserved market of people who exercise regularly, eat well, and want a clinically backed tool to lose stubborn body fat, build lean muscle, and recover faster. That market is yours to build.
The Body Composition Peptide Stack
The core of a body composition peptide brand is growth hormone optimization combined with targeted lipolysis. The most common protocols include:
CJC-1295 + Ipamorelin (GH Secretagogue Stack) The foundational growth hormone stack. CJC-1295 is a synthetic GHRH analog that stimulates the pituitary to produce and release growth hormone. Ipamorelin is a selective GH secretagogue that amplifies the GH pulse. Together, they produce a more robust GH response than either compound alone.
Results over 8 to 16 weeks of consistent use include increased lean muscle mass, reduced body fat (particularly abdominal fat), improved sleep quality, faster recovery between workouts, and better skin and connective tissue quality. Clinical data on CJC-1295 and related GHRH analogs supports these outcomes in adults with age-related GH decline (Teichman et al., Journal of Clinical Endocrinology and Metabolism, 2006).
Tesamorelin Tesamorelin is an FDA-approved GHRH analog (approved as Egrifta for HIV-associated lipodystrophy) with particularly strong data on visceral fat reduction. Off-label, it is used for individuals with elevated visceral adiposity who want targeted abdominal fat loss. It is one of the best-documented peptides for body composition in clinical literature.
AOD-9604 AOD-9604 is a modified fragment of human growth hormone specifically selected for lipolytic (fat-burning) activity without the growth-promoting or insulin-resistance effects of full HGH. It acts on beta-3 adrenergic receptors to stimulate fat breakdown. It is an ideal adjunct for patients whose primary goal is fat loss rather than muscle building.
Who Is Your Customer?
A body composition peptide brand does not target the same person as a weight loss GLP-1 brand. Your customer:
- Already exercises consistently (gym, CrossFit, running, cycling, etc.)
- Has reached a fitness plateau despite good habits
- Has visible results from training but wants to accelerate fat loss or muscle gain
- Is interested in longevity and performing well as they age
- Is probably 30 to 55 years old
- Already spends money on personal training, supplements, or coaching
This is a motivated, knowledgeable buyer with a demonstrated willingness to invest in their body. They are not seeking a shortcut — they are seeking an edge.
Why Fitness Professionals Have a Natural Advantage
If you are a personal trainer, strength coach, sports nutritionist, or fitness influencer, you already have something that makes this business far easier than building from scratch: trust.
Your audience has seen your results. They follow your advice on training and nutrition. When you add a physician-supervised peptide program under your brand, you are not selling them an unfamiliar product — you are giving them access to something they have probably already been researching.
This trust advantage translates directly to economics. Operators with established fitness audiences typically acquire patients for $25 to $75. Cold digital acquisition for body composition peptide programs runs $150 to $300 because the category is still relatively unknown to mass audiences.
The Business Model
A body composition peptide brand runs on recurring subscriptions:
| Program Tier | Monthly Price | Compounds |
|---|---|---|
| Core | $199 to $249 | CJC-1295 + Ipamorelin |
| Advanced | $299 to $349 | CJC-1295 + Ipamorelin + AOD-9604 |
| Performance | $379 to $449 | Full protocol including Tesamorelin |
Platform and pharmacy costs run $80 to $120 per patient depending on protocol complexity. Operator net margin is typically 40 to 55 percent of gross revenue.
Patient lifetime is 6 to 12 months on the active results protocol. Many patients transition to a maintenance program at reduced cost and frequency, extending the relationship further.
Building the Brand
Your brand identity for a body composition peptide program should communicate:
- Scientific credibility (physician-supervised, clinically validated compounds)
- Performance orientation (this is for people who take their body seriously)
- Specificity to your audience (gym community, competitive athletes, biohackers, etc.)
- Accessibility (patients do not need to visit a clinic — everything is handled online)
Your platform handles all clinical infrastructure: intake forms, physician evaluation, prescription, compounding pharmacy, and patient portal. You handle brand voice, content, and growth.
Compliance in the Fitness Space
Marketing body composition products to fitness audiences requires care around one specific area: implied performance enhancement claims.
Phrases like “build muscle fast,” “pharmaceutical-grade performance,” or language that implies the peptides are similar to anabolic steroids creates regulatory and platform policy risk. The better framing is physician-supervised hormonal optimization — which is accurate, clinical, and defensible.
FTC disclosure requirements apply to all claims and testimonials. Patient results in your marketing must be typical or clearly disclosed as atypical.
The Next Step
If you have a fitness audience or brand, a body composition peptide program is one of the most aligned products you can offer. The clinical outcomes are real, the recurring revenue is strong, and the patient profile matches the fitness community’s existing values around investing in health.
Book a call with Karpa Health to walk through what a body composition peptide brand looks like under your name.
For more context on closely related topics, read CJC-1295 and Ipamorelin program guide, MOTS-c metabolic program guide, and Wolverine Stack program guide.